Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
FIH
-mediated post-translational modification through asparaginyl hydroxylation of eukaryotic proteins impacts regulation of protein-protein interaction. We have identified the
FIH
recognition motif in 11
Legionella
pneumophila
translocated effectors, YopM of
Yersinia
, IpaH4.5 of
Shigella
and an ankyrin protein of
Rickettsia
. Mass spectrometry analyses of the AnkB and AnkH effectors of
L. pneumophila
confirm their asparaginyl hydroxylation. Consistent with localization of the AnkB effector to the
Legionella
-containing vacuole (LCV) membrane and its modification by
FIH
, our data show that
FIH
and its two interacting proteins, Mint3 and MT1-MMP are acquired by the LCV in a Dot/Icm type IV secretion-dependent manner. Chemical inhibition or RNAi-mediated knockdown of
FIH
promotes LCV-lysosomes fusion, diminishes decoration of the LCV with polyubiquitinated proteins, and abolishes intra-vacuolar replication of
L. pneumophila
. These data show acquisition of the host
FIH
by a pathogen-containing vacuole and that asparaginyl-hydroxylation of translocated effectors is indispensable for their function.
...
PMID:Host FIH-Mediated Asparaginyl Hydroxylation of Translocated
Legionella pneumophila
Effectors. 2832 89